ONCOSIL MEDICAL LIMITED ABN 89 113 824 141 ASX | OSL Level 5, 7 Eden Park Drive, Macquarie Park, NSW 2113 AUSTRALIA TELEPHONE +61 2 8935 9629 WEB www.oncosil.com 1 ASX Announcement 30 July 2026 Quarterly Activities & Cash Flow Report Quarter ended 30 June 2026 ...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- OncoSil Medical Completes Manufacturing Validation
- OncoSil Medical Files for FDA Approval
- OncoSil Selected for Major European Pancreatic Cancer Study
- OncoSil progresses HDE with US FDA
- OncoSil Medical Receives TGA Approval in Australia
Later from OncoSil Medical
- OncoSil Receives FDA Approval for Distal Cholangiocarcinoma
- Investor Webinar Presentation
- Application for quotation of securities - OSL
- Change in substantial shareholding for OSL
- Change in substantial holding
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical